Details
Question
- What is the clinical effectiveness of universal versus high risk palivizumab prophylaxis for respiratory syncytial virus prevention in Inuit infants?
- What is the clinical effectiveness of seasonal versus year-round palivizumab prophylaxis for respiratory syncytial virus prevention in Inuit infants?
- What is the cost- effectiveness of universal versus high risk palivizumab prophylaxis for respiratory syncytial virus prevention in Inuit infants?
- What is the cost-effectiveness of seasonal (~6months) versus year-round palivizumab prophylaxis for respiratory syncytial virus prevention in Inuit infants